Drug Insights

User-friendly Guide to Find Clonidine on Synapse

9 February 2024
2 min read

Clonidine lowers blood pressure by stimulating α2 receptors in the brain, which results in relaxation of many arteries. Clonidine was patented in 1961 and came into medical use in 1966. Clonidine, sold under the brand name Catapres among others, is an α2-adrenergic agonist medication used to treat high blood pressure, ADHD, drug withdrawal (alcohol, opioids, or nicotine), menopausal flushing, diarrhea, spasticity, and certain pain conditions. It is used by mouth, by injection, or as a skin patch. Onset of action is typically within an hour with the effects on blood pressure lasting for up to eight hours. Common side effect include dry mouth, dizziness, headaches, hypotension, and sleepiness. Severe side effects may include hallucinations, heart arrhythmias, and confusion. If rapidly stopped, withdrawal effects may occur. Click on the image below to begin the exploration journey of Clonidine through the Synapse database!

图形用户界面, 应用程序

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

DP Tech Unveils Kv1.3 Blocker Candidate for IBD and AD Treatment
Latest Hotspot
3 min read
DP Tech Unveils Kv1.3 Blocker Candidate for IBD and AD Treatment
9 February 2024
DP Tech has revealed its selection of a developmental contender, a promising top-tier Kv1.3 blocker aimed at tackling immune disorders like IBD and AD.
Read →
Harnessing Synapse for Montelukast Information: Strategies and Tips
Drug Insights
2 min read
Harnessing Synapse for Montelukast Information: Strategies and Tips
9 February 2024
SINGULAIR® (Montelukast sodium) is a drug for treating asthma, exercise-induced bronchoconstriction (EIB), and allergic rhinitis.
Read →
EicOsis Begins Phase 1b Study for EC5026 in Clinical Settings
Latest Hotspot
3 min read
EicOsis Begins Phase 1b Study for EC5026 in Clinical Settings
7 February 2024
EicOsis Human Health has announced the advancement of its clinical research program, beginning a Phase 1b trial to assess the safety of its experimental drug, EC5026, through increasing dosages.
Read →
Effortless Searching: How to Find Finasteride on Synapse
Drug Insights
2 min read
Effortless Searching: How to Find Finasteride on Synapse
7 February 2024
Finasteride, sold as PROSCAR®, is a 5α-reductase inhibitor mainly used to treat men with benign prostatic hyperplasia (BPH) symptoms with enlarged prostates.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.